BioXcel Therapeutics Aktie
WKN DE: A2JF20 / ISIN: US09075P1057
27.03.2025 12:26:45
|
BioXcel Therapeutics, Inc. Q4 Loss Declines
(RTTNews) - BioXcel Therapeutics, Inc. (BTAI) announced Loss for fourth quarter of -$10.86 million
The company's bottom line came in at -$10.86 million, or -$3.57 per share. This compares with -$22.26 million, or -$12.09 per share, last year.
The company's revenue for the period fell 2.6% to $0.37 million from $0.38 million last year.
BioXcel Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$10.86 Mln. vs. -$22.26 Mln. last year. -EPS: -$3.57 vs. -$12.09 last year. -Revenue: $0.37 Mln vs. $0.38 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BioXcel Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |